Spyre Therapeutics Inc. (SYRE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.88B
Last updated: Nov 17, 2026 at 11:06 AM ET
Spyre Therapeutics Inc. (SYRE) Competitors
The companies most similar to Spyre Therapeutics are TG Therapeutics (TGTX), Apogee Therapeutics, Inc. Common Stock (APGE) and Kymera Therapeutics (KYMR). By market cap, Spyre Therapeutics ranks 6th of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B. The median P/E of the 4 companies with a P/E is 40.0x.
Peer Comparison
SYRE's revenue growth of 0.0% is below the peer median of 41.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Spyre Therapeutics (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Kymera Therapeutics Inc (KYMR) | $10.89B | N/A | 123.2x | 0.0% | N/A | 466.4% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Abivax SA American Depositary Shares (ABVX) | $7.67B | N/A | N/A | 0.0% | -159.6% | -6.8% | 0.00% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Twist Bioscience Corp (TWST) | $7.40B | N/A | 14.3x | -28.3% | N/A | 27.9% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| Peer median | $9.46B | 40.0x | 15.0x | 0.0% | -33.0% | 41.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Spyre Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... | |
| Kymera Therapeutics Inc (KYMR) | Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down... | KYMR competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Abivax SA American Depositary Shares (ABVX) | Abivax SA is a clinical-stage biotechnology firm focused on pioneering immunotherapies for chronic inflammatory diseases and viral infections. | ABVX competitors |
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| Twist Bioscience Corp (TWST) | Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. | TWST competitors |
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
Frequently Asked Questions About SYRE
Who are Spyre Therapeutics' main competitors?
The companies most similar to Spyre Therapeutics include TG Therapeutics (TGTX), Apogee Therapeutics, Inc. Common Stock (APGE), Kymera Therapeutics (KYMR), Summit Therapeutics (SMMT) and Protagonist Therapeutics (PTGX), listed from the closest match.
Who is Spyre Therapeutics' biggest competitor?
BridgeBio Pharma (BBIO) is the largest of the similar companies at $15.25B; TG Therapeutics (TGTX) is the closest match by business profile, size, sector and industry.
How does SYRE stock compare with its competitors?
SYRE's net margin is 0.0% against a peer median of 0.0%.
Which of Spyre Therapeutics' competitors pays a higher dividend?
Spyre Therapeutics pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is Spyre Therapeutics bigger than its competitors?
No. Spyre Therapeutics is 6th by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.
SYRE pages: Overview, Earnings, Forecast, Financials, Competitors